apparent in the early new-born period. Routine neonatal examination fails to detect >50% of infants with CCVM. 5 Most new-borns with Critical Congenital Heart Disease (CCHD) can be diagnosed by echocardiography, palliated with prostaglandin infusion, and treated with surgery or transcatheter interventions. In the current era, congenital heart surgery allows for repair or palliation of nearly all types of congenital heart malformations. Congenital heart surgery, together with transcatheter interventions, has resulted in a marked improvement in survival for those with CCHD. 6 Intervention is typically performed in the first weeks of life to optimize hemodynamics and prevent end-organ injury associated with delayed diagnosis. Because timely recognition of congenital heart malformations could improve outcomes, it is important to identify and evaluate strategies to enhance early detection. Pulse oximetry has been proposed as one such strategy, and legislation has been proposed to support this practice. 7 Oximetric screening for CCVM seems to satisfy the requirements for a screening test: 1) the prevalence of CCVM among asymptomatic new-borns is high, particularly in areas with lower rates of fetal echocardiography; 2) the technique of oximetric screening is simple and reliable, 3) effective cardiovascular interventions are available, and 4) the cost/benefit ratio of this screening test is favorable. No costs were incurred for equipment, supplies, or personnel, and two asymptomatic new-borns were prevented from going home with undiagnosed CCVM.
METHODS

Design
Hospital-based, cross sectional study from August 2010 to July 2011.
Settings
The study was conducted at department of paediatrics in L.D. hospital (Neonatology ward) -hospital A and G.B. Panth hospital (Neonatology ward) -hospital B, with the catchment area of both rural and urban populations.
Both these hospitals are tertiary care hospitals associated with government medical college, Srinagar, Kashmir.
Inclusion criteria
All asymptomatic new-borns attending G.B. Panth, neonatology/L.D. neonatology who did not manifest cyanosis, tachypnea (respiratory rate >60/min), grunting, flaring, retractions, murmur, active precordium, or diminished pulses were screened with pulse oximetry.
Approach
Oximetric screening for congenital cardiovascular malformations was performed by obtaining a single determination of post-ductal saturation on all asymptomatic new-borns that fulfilled the inclusion criteria.
Nelcor oximax pulse oximeter was used to determine post-ductal saturation. The probe was placed over left foot. To ensure universal screening, the timing of oximetric determination was >24 hours age. All these new-borns underwent additional evaluation by echocardiography which is considered as gold standard. Data regarding true and false positives as well as negatives was collected and sensitivity, specificity and predictive values of pulse oximetry screening of asymptomatic new-borns for CCVM were determined.
Statistical calculations
True positives were defined as those new-borns who were screened with pulse oximetry with SpO 2 ≤95% and, echocardiography revealed a congenital heart disease.
True negatives were defined as those new-borns who were screened with pulse oximetry with SpO 2 >95% and, echocardiography revealed structurally normal heart. False positives were defined as those new-borns who were screened with pulse oximetry with SpO 2 ≤95%, but echocardiography revealed structurally normal heart. False negatives were defined as those new-borns who were screened with pulse oximetry with SpO 2 >95%, but echocardiography revealed a congenital heart disease.
RESULTS
A cross sectional study was conducted on all asymptomatic newborns attending the neonatology ward of hospital A and hospital B comprising 940 and 260 newborns respectively. Various epidemiological parameters obtained in the study group are summarized in Table 1 .
A single determination of post-ductal saturation was obtained on all asymptomatic new-borns at ≥24 hours of age. All new-borns underwent additional evaluation by echocardiography.
Out of 1200 asymptomatic neonates, post-ductal desaturation (PO 2 ≤95%) was seen in only three (Table  2) . Echocardiography revealed Transposition of Great Vessels (TGA) in one Truncus Arteriosus (TA) in other and third one had structurally normal heart on echocardiography (false positive). One false negative screen having dextro transposition of great arteries with ventricular septal defect (dTGA + VSD) was found on echocardiography in hospital B.
Various statistical parameters obtained are summarised in Table 3 . Therefore, 1 in 600 asymptomatic newborns was found to have a CCVM by oximetric screening before discharge.
There was no accrued cost as reusable oximeter probes were used with oximeters already in place in the neonatology wards.
DISCUSSION
Congenital heart defects are the most common group of congenital malformations. Early detection of major congenital heart defects (i.e.; those leading to death or requiring invasive intervention before 1 year of age) might improve the outcome of new-born babies. 8 Improvement with early detection is particularly true for critical, duct-dependent lesions in which closure of the ductus arteriosus can result in acute cardiovascular collapse, acidosis, and death. [9] [10] [11] Screening for congenital heart defects relies on mid-trimester ultrasound scan in which the fetal heart chambers are imaged, and postnatal physical examination that includes assessment of pulses and heart sounds and inspection for cyanosis. Both screening methods have a fairly low detection rate and a substantial number of babies are discharged from hospital before congenital heart defects are diagnosed. 5, [12] [13] [14] [15] Some of these babies die or present in such a poor clinical state that the outcome, despite treatment, is compromised.
Pulse oximetry is a well-established, accurate, noninvasive test for objective quantification of hypoxaemia. Use of this screening method for early detection of congenital heart defects is based on the rationale that clinically undetectable hypoxaemia is present, to some degree, in most potentially life-threatening cases. Pulse oximetry has been assessed as a screening method for congenital heart defects in new-born babies in many studies. [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] Out of 1200 asymptomatic newborns screened by pulse oximetry only 3 cases were found to have SPO 2 ≤95%. These 3 cases further underwent echocardiography to confirm the findings of screening test. 2 out of 3 cases were detected to have CCVM. Thus, prevalence of CCVM in asymptomatic newborns was found to be 1 in 600 (0.16%). Our results were comparable with those obtained by Tautzet al. 27 and Arlettaz et al. 23 Tautzet al. 27 found that CCVM was identified using pulse oximetric screening in 1 in 1000 asymptomatic newborns (0.1%). Another study conducted by Arlettaz and 23 in 3262 newborns found that there were 11 cases of CCVM in asymptomatic neonates with SPO 2 <95% giving the prevalence of 1 in 297 (0.33%).
The sensitivity was found to be 66.67% which is comparable to the results obtained by Koppel et al. 19 , Bakr et al. 22 , Rosati et al. 21 and Richmond et al. 17 (60.0%, 60.0%, 66.7% and 69.2% respectively). Nine out of ten studies in a review by Mahle et al. 28 found sensitivities to be less than 90%, ranging from 0% to 87%. This is explained in part by the fact that hypoxemia is not present in some forms of CCHD.
The specificity was found to be 99.9% which is again comparable to the studies conducted by other workers. 17, 19, 22 The positive predictive value of 66.67% was comparable to that obtained by Rosati et al. 21 who obtained a PPV of 66.7%. However, it is less than that obtained by most of the other workers like Koppel et al., 19 Arlettaz et al. 23 and others but more than that obtained by Richmond et al. 17 and Hoke et al. 16 The negative predictive value of 99.9% is comparable to all other studies which have reported it to be between 98% to 100%. [16] [17] [18] [19] [21] [22] [23] The false positive rate was found to be 0.08% and was comparable to that obtained by Reich et al. 18 who reported it to be 0.09% at >24 hours. A low false positive rate reduces the number of unnecessary echocardiograms.
Limitations of the study
1.
The sample size is relatively small and makes the calculation of effectiveness of pulse oximetry screening relatively difficult.
2.
We assumed that all the diagnosis were to be made at G.B. Panth and L.D. hospital; we could, however, have missed a small number of infants diagnosed elsewhere.
CONCLUSION
Pulse oximetry is a safe, non-invasive, feasible, and reasonably accurate test, which has a sensitivity that is better than that of antenatal screening and clinical examination.
 It adds value to existing screening procedures and is likely to be useful for identification of cases of critical congenital heart defects that would otherwise go undetected.
 The detection of other diseases such as significant congenital heart defects, and respiratory and infective illnesses is an additional advantage.
 The results of this study agree with the strong evidence that indicates the potential benefits of the introduction of pre-discharge pulse oximetry screening as a routine procedure.
To conclude, various studies and review articles all over the globe have suggested the usefulness of pulse oximetry screening for detecting the congenital cardio vascular malformations in asymptomatic new-borns. However, very little research has been done in this particular field in our country. This study adds to the evidence in support of starting the pulse oximetry as a routine neonatal screening programme to let many a children to live a long life with healthy hearts.
